GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Clinical trial NCT07297667 · RECRUITING

Trial details

NCT number: NCT07297667
Sponsor: Canadian Cancer Trials Group
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alveolar Soft Part Sarcoma Renal Cell Carcinoma Triple Negative Breast Cancer

Start date: 2026-07-30
Primary completion: 2028-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.